Plus Therapeutics to become Cerenome, to trade under new Nasdaq ticker CNSY on August 3, 2026Affirms 2026 guidance on key milestones Reports ...

Replimune Group, Inc. nears a pivotal FDA AdCom for RP1 ahead of an Aug 2, 2026 decision. Click for this REPLY stock update ...

Plus Therapeutics to become Cerenome, to trade under new Nasdaq ticker CNSY on August 3, 2026 Affirms 2026 guidance on key milestones Reports positive CNSide commercial progress HOUSTON, June 30, 2026 ...

On football Twitter, terms like ‘Brexit football’, ‘Barclaysman’ and ‘the streets won’t forget’ are getting thrown about all ...

(Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Trodelvy ® (sacituzumab govitecan-hziy), a first-in-class Trop-2-directed antibody-drug conjugate (ADC), ...

NeuroSense Therapeutics Ltd. ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced positive biomarker findings ...

Rett syndrome is a devastating rare and progressive neurodevelopmental disease with high unmet need and a profound lifelong burden for patients and caregivers. It is well characterized clinically ...

Detailed price information for Greenwich Lifesciences Inc (GLSI-Q) from The Globe and Mail including charting and trades.

King Henry VIII and Bablake School in Coventry were found by inspectors to have missed standards.

June 8, 2026 – Washington, D.C.—The Commercial Space Federation (CSF) is pleased to welcome Besxar and Charter Space as new space supply chain members, adding expertise in space-based semiconductor ...

The triangle taught me how to think about information security. The pentagon taught me how to think about organizational ...

Biomedical engineers at Duke University have developed a technique to noninvasively visualize the brain's waste-removal system in unprecedented detail. This new imaging approach allows researchers to ...